Neurosense Therapeutics Ltd (NRSN)

Neurosense Therapeutics Ltd (NRSN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.8M; returns 1 day +0.8%, 1 week -19.9%, 1 year -89.4%.

Neurosense Therapeutics Ltd. (NRSN) is a clinical-stage biotechnology company primarily focused on discovering and developing novel treatments for severe neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease, and Parkinson's disease.

Groups NRSN belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Israel Companies
• Biotechnology
• Neuroscience
• Healthcare
• Alzheimer's Disease
• CNS Disorders
• Neurological Disorders
• Israel
• Rare Diseases
• Life Sciences

NRSN financial model: income statement, cash flow and balance sheet